India to Ecuador: Digoxin Export Trade Route

The India to Ecuador Digoxin corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $66.7K USD. The route is dominated by CARITAS HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's digoxin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $22.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with digoxin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 25.3%, placing it at rank #14 among India's top digoxin export destinations globally.

On the import side, key buyers of Indian digoxin in Ecuador include F.D.E.C.A, TO THE PURCHASE MANAGER . F.D.E.C.A is the single largest importer with 2 shipments valued at $38.7K USD.

India's digoxin exports to Ecuador are driven primarily by a handful of large-scale manufacturers. CARITAS HEALTHCARE PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Ecuador benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CARITAS HEALTHCARE PRIVATE LIMITED, CARITAS HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $22.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as digoxin injection 0.25mg/ml batch no.gn9 and human products finished pharmaceutical product - digoxin injection 0.25mg./ml, suggesting that buyers in Ecuador tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, F.D.E.C.A is the largest importer with 2 shipments worth $38.7K USD — representing 58% of all digoxin imports from India on this route.